Carcinogenesis in tuberous sclerosis

Gann Monographs on Cancer Research

Volumn 46, Issue , 1999, Pages 101-111

  Hino, Okio ^a   Satake, Nobuo ^a   Kobayashi, Toshiyuki ^a   Kajino, Kazunori ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOSOMAL DOMINANT DISORDER; CANCER SUSCEPTIBILITY; CHROMOSOME 16; CONFERENCE PAPER; FAMILIAL CANCER; GENETIC ANALYSIS; GENETIC MARKER; GENETIC SUSCEPTIBILITY; HETEROZYGOSITY LOSS; HUMAN; KIDNEY CARCINOMA; MALIGNANT TRANSFORMATION; MOLECULAR CLONING; PRIORITY JOURNAL; TUBEROUS SCLEROSIS;

EID: 0032990604     PISSN: 00720151     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (52)

1. Bannasch, P. and Zerban, H. Animal models and renal carcinogenesis. In "Tumors and Tumor-like Conditions of the Kidneys and Ureters," ed. J.N. Ebel, pp. 1-34 (1990). Churchill Livingstone, New York.
2. Cairns, P., Tokino, K., Eby, Y., and Sidransky, D. Localization of tumor suppressor loci on chromosome 9 in primary human renal cell carcinomas. Cancer Res., 55, 224-227 (1995).
3. Eker, R. and Mossige, J. A dominant gene for renal adenomas in the rats. Nature, 189, 858-859 (1961).
4. Everitt, J.I., Goldsworthy, T.L., Wolf, D.S., and Walker, C.L. Hereditary renal cell carcinoma in the Eker rat: a rodent familial cancer syndrome. J. Urol., 148, 1932-1936 (1992).
5. Fukuda, T., Mitani, H., Tsutsumi, M., Konishi, Y., and Hino, O. Specific induction of hepatocellular adenomas by transplacental administration of ENU in the Tsc2 gene mutant (Eker) rat. Int. J. Oncol., 13, 957-961 (1998).
6. Fukuda, T., Hirayama, Y., Mitani, H., Maeda, H., Konishi, Y., and Hino, O. Generation of metastatic variants of Eker renal carcinoma cell lines for experimental investigation of renal cancer metastasis. Jpn. J. Cancer, 89, 1-5 (1998).
7. Gnarra, J.R. Mutations of the VHL tumor suppressor gene in renal carcinoma. Nature Genet., 7, 85-90 (1994).
8. Green, A.J., Smith, M., and Yates, J.R.W. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients. Nature Genet., 6, 193-196 (1994).
9. Henry, K.W., Yuan, X., Koszewski, N.J., Onda, H., Kwiatkowski, D.J., and Noonan, D.J. Tuberous sclerosis gene 2 product modulates transcription mediated by steroid hormone receptor family members. J. Biol. Chem., 273, 20535-20539 (1998).
10. Hino, O., Klein-Szanto, A.J.P., Freed, J.J. et al. Spontaneous and radiation-induced renal tumors in the Eker rat model of dominantly inherited cancer. Proc. Natl. Acad. Sci. USA, 90, 327-331 (1993).
11. Hino, O., Testa, J., Buetow, K. et al. Universal mapping probes and origin of human chromosome 3. Proc. Natl. Acad. Sci. USA, 90, 730-734 (1993).
12. Hino, O., Mitani, H., and Knudson, A.G. Genetic predisposition to transplacentally induced renal cell carcinomas in the Eker rat. Cancer Res., 53, 5856-5858 (1993).
13. Hino, O., Mitani, H., Nishizawa, M., Katsuyama, H., Kobayashi, E., and Hirayama, Y. A novel renal cell carcinoma susceptibility gene maps on chromosome 10 in the Eker rat. Jpn. J. Cancer Res., 84, 1106-1109 (1993).
14. Hino, O., Mitani, H., Katsuyama, H., and Kubo, Y. A novel cancer predispostion syndrome in the Eker rat model. Cancer Lett., 83, 117-121 (1994).
15. Hino, O., Kobayashi, T., Tsuchiya, H. et al. The predisposing gene of the Eker rat inherited cancer syndrome is tightly linked to the tuberous sclerosis (Tsc2) gene. Biochem. Biophys. Res. Commun., 203, 1302-1308 (1994).
16. Hino, O., Kobayashi, T., Mitani, H. et al. The Eker rat, a model of dominantly inherited cancer syndrome. Transplantation Proc., 27, 1529-1531 (1995).
17. Hino, O., Kobayashi, E., Nishizawa, M. et al. Renal carcinogenesis in the Eker rat. J. Cancer Res. Clin. Oncol., 121, 602-605 (1995).
18. Hino, O., Kobayashi, E., Hirayama, Y. et al. Molecular genetic basis of renal carcinogenesis in the Eker rat model of tuberous sclerosis (Tsc2). Mol. Carcinog., 14, 23-27 (1995).
19. Jin, F., Wienecke, R., Xiao, G.H., Maize, J.C.Jr., DeClue, J.E., and Yeung, R.S. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proc. Natl. Acad. Sci. USA, 93, 9154-9159 (1996).
20. Kajino, K., Yakurai, J., Hirayama, Y. et al. LOH of tumor suppressor TSC2 gene locus in human renal cell carcinomas and lung carcinomas. Proc. Jpn. Cancer Assoc., 279 (1997).
21. Kikuchi, Y., Kobayashi, E., Nishizawa, M., Hamazaki, S., Okada, S., and Hino, O. Cloning of the rat homologue of the von Hippel-Lindau tumor suppressor gene and its non-somatic mutation in rat renal cell carcinomas. Jpn. J. Cancer Res., 86, 905-909 (1995).
22. Knudson, A.G. Mutation and cancer: statistical study of retinoblastoma. Proc. Natl. Acad. Sci. USA, 68, 820-823 (1971).
23. Knudson, A.G. Hereditary cancer, oncogenes, and antioncogenes. Cancer Res., 45, 1437-1443 (1985).
24. Kobayashi, T., Hirayama, Y., Kobayashi, E., Kubo, Y., and Hino, O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nature Genet., 9, 70-74 (1995).
25. Kobayashi, T., Nishizawa, M., Hirayama, Y., Kobayashi, E., and Hino, O. cDNA structure, alternative splicing and exon-intron organization of the predisposing tuberous sclerosis (Tsc2) gene of the Eker rat model. Nucl. Acids Res., 23, 2608-2613 (1995).
26. Kobayashi, T., Mitani, H., Takahashi, R. et al. Transgenic rescue from embryonic lethality and renal carcinogenesis in the Eker rat model by introduction of a wild-type Tsc2 gene. Proc. Natl. Acad. Sci. USA, 94, 3990-3993 (1997).
27. Kobayashi, T., Urakami, S., Cheadle, J.P. et al. Identification of a leader exon and a core promoter for the rat tuberous sclerosis 2 (Tsc2) gene and structural comparison with the human homologue. Mammal. Genome, 8, 554-558 (1997).
28. Kobayashi, T., Urakami, S., Hirayama, Y. et al. Intragenic Tsc2 somatic mutations as Knudson's second hit in spontaneous and chemically induced renal carcinomas in the Eker rat model. Jpn. J. Cancer Res., 88, 254-261 (1997).
29. Kubo, Y., Mitani, H., and Hino, O. Allelic loss at the predisposing gene locus in spontaneous and chemically induced renal cell carcinomas in the Eker rat. Cancer Res., 54, 2633-2635 (1994).
30. Kubo, Y., Kikuchi, Y., Mitani, H., Kobayashi, E., Kobayashi, T., and Hino, O. Allelic loss at the tuberous sclerosis (Tsc2) gene locus in spontaneous uterine leiomyosarcomas and pituitary adenomas in the Eker rat model. Jpn. J. Cancer Res., 86, 828-832 (1995).
31. Kubo, Y., Klimek, F., Kikuchi, Y., Bannasch, P., and Hino, O. Early detection of Knudson's two-hits in preneoplastic renal cells of the Eker rat model by the laser microdissection procedure. Cancer Res., 55, 989-990 (1995).
32. Kumar, A., Wolpert. C., Kandt, R.S. et al. De novo frame-shift mutation in the tuberin gene. Hum. Mol. Genet., 4, 1471-1472 (1995).
33. Lindor, N.M. and Greene, M.H., The Mayo Familial Cancer Program. The Concise Handbook of Family Cancer Syndromes. J. Natl. Cancer Inst., 90, 1039-1071 (1998).
34. Miki, S., Miki, Y., Mitani, H., Sato, B., Yamamoto, M., and Hino, O. Hyperlipidemia enhancement of renal preneoplasia but not tumor formation is due to elevated apoptosis in the Eker rat. Cancer Res., 57, 4673-4676 (1997).
35. Orimoto, K., Tsuchiya, H., Kobayashi, T., Matsuda, T., and Hino, O. Suppression of the neoplastic phenotype by replacement of the Tsc2 gene in Eker rat renal carcinoma cells. Biochem. Biophys. Res. Commun., 219, 70-75 (1996).
36. Orimoto, K., Tsuchiya, H., Sakurai, J., Nishizawa, M., and Hino, O. Identification of cDNAs induced by the tumor suppressor Tsc2 gene using conditional expression system in Tsc2 mutant (Eker) rat renal carcinoma cells. Biochem. Biophys. Res. Commun., 247, 728-733. (1998).
37. Satake, N., Urakami, S., Hirayama, Y., Izumi, K., and Hino, O. Biallelic mutations of the Tsc2 gene in chemically induced rat renal carcinoma. Int. J. Cancer, 77, 895-900 (1998).
38. Testa, J.R., Taguchi, T., Knudson, A.G., and Hino, O. Localization of the interferon-a gene cluster to rat chromosome bands 5q31-q33 by fluorescence in situ hybridization. Cytogenet. Cell Genet., 60, 247-249 (1992).
39. The European Chromosome 16 Tuberous Sclerosis Consortium: identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell, 75, 1305-1315 (1993).
40. Tsuchiya, H., Tsuchiya, Y., Kobayashi, T., Kikuchi, Y., and Hino, O. Isolation of genes differentially expressed between the Yoshida sarcoma and long-survival Yoshida sarcoma variants: origin of Yoshida sarcoma revisited. Jpn. J. Cancer Res., 85, 1099-1104 (1994).
41. Tsuchiya, H., Orimoto, K., Kobayashi, T., and Hino, O. Presence of potent transcriptional activation domains in the predisposing tuberous sclerosis (Tsc2) gene product of the Eker rat model. Cancer Res., 56, 429-433 (1996).
42. Urakami, S., Tsuchiya, H., Orimoto, K., Kobayashi, T., Igawa, M., and Hino, O. Overexpression of members of the AP-1 transcriptional factor family from an early stage of renal carcinogenesis and inhibition of cell growth by AP-1 gene antisense oligonucleotides in the Tsc2 gene mutant (Eker) rat model. Biochem. Biophys. Res. Commun., 241, 24-30 (1997).
43. Urakami, S., Tokuzen, R., Tsuda, H., Igawa, M., and Hino, O. Somatic mutation of the tuberous sclerosis (Tsc2) tumor suppressor gene in chemically induced rat renal carcinoma cell. J. Urol., 158, 275-278 (1997).
44. van Slegtenhorst, M., de Hoogt, R., Hermans, C. et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science, 277, 805-808 (1997).
45. van Slegtenhorst, M., Nellist, M., Nagelkerken, B. et al. Interaction between harmartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet., 7, 1053-1057 (1998).
46. Walker, C., Goldsworthy, T.L., Wolf, D.C., and Everitt, J. Predisposition to renal cell carcinoma due to alteration of a cancer susceptibility gene. Science, 255, 1693-1695 (1992).
47. Wienecke, R., Koning, A., and DeClue, J.E. Identification of tuberin, the tuberous sclerosis 2 product. J. Biol. Chem., 207, 16409-16414 (1995).
48. Xiao, G.H., Shoarinejad, F., Jin, F., Golemis, E.A., and Yeung, R.S. The TSC2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. J. Biol. Chem., 272, 6097-6100 (1997).
49. Yeung, R.S., Buetow, K.H., Testa, J.R., and Knudson, A.G. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc. Natl. Acad. Sci. USA, 90, 8038-8042 (1993).
50. Yeung, R.C., Xiao, G.H., Jin, F., Lee, W-C., Testa, J.R., and Knudson, A.G. Predisposition to renal carcinoma in the Eker rat is determined by germ-line mutation of the tuberous sclerosis 2 (TSC2) gene. Proc. Natl. Acad. Sci. USA, 91, 11413-11416 (1994).
51. Yeung, R.S., Katsetos, C.D., and Klein-Szanto, A. Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis. Am. J. Pathol., 151, 1477-1486 (1997).
52. Zimmerhackl, L.B., Rehm, M., Kaufmehl, K., Kurlemann, G., and Brandis, M. Renal involvement in tuberous sclerosis complex; a retrospective study. Pediatr. Nephrol., 8, 451-457 (1994).